- improved glucose tolerance / IMPC
- increased bone mineral content / IMPC
- decreased locomotor activity / IMPC
- increased erythrocyte cell number / IMPC
- decreased fasting circulating glucose level / IMPC
- increased heart weight / IMPC
- decreased circulating total protein level / IMPC
- increased circulating alkaline phosphatase level / IMPC
- increased anxiety-related response / IMPC
- decreased circulating cholesterol level / IMPC
- decreased exploration in new environment / IMPC
- male infertility / IMPC
- increased leukocyte cell number / IMPC
- thrombocytopenia / IMPC
- decreased blood urea nitrogen level / IMPC
- decreased circulating HDL cholesterol level / IMPC
- increased circulating bilirubin level / IMPC
- decreased circulating triglyceride level / IMPC
- decreased circulating serum albumin level / IMPC
- increased circulating aspartate transaminase level / IMPC
- increased hematocrit / IMPC
- abnormal cholesterol homeostasis / IMPC
- decreased mean corpuscular volume / IMPC
- decreased circulating glucose level / IMPC
- abnormal skin coloration / IMPC
- decreased mean corpuscular hemoglobin / IMPC
- abnormal retina blood vessel morphology / IMPC
- increased circulating alanine transaminase level / IMPC
- increased startle reflex / IMPC
C57BL/6NTac-Atp13a3em2H/H
Status | Available to order |
EMMA ID | EM:12528 |
International strain name | C57BL/6NTac-Atp13a3em2H/H |
Alternative name | ATP13A3-P452LFS-EM2-B6N |
Strain type | Endonuclease-mediated |
Allele/Transgene symbol | Atp13A3em2H |
Gene/Transgene symbol | Atp13a3 |
Information from provider
Provider | MRC-Harwell |
Provider affiliation | Mary Lyon Centre at MRC Harwell |
Genetic information | For detailed information on the genetic description of this strain, please have a look at this report. |
Phenotypic information | Homozygous:Not knownHeterozygous:None reported |
Breeding history | Co-isogenic on original background |
References | None available |
Homozygous fertile | yes |
Homozygous viable | not known |
Homozygous matings required | no |
Immunocompromised | not known |
Information from EMMA
Archiving centre | Mary Lyon Centre at MRC Harwell, Oxford, United Kingdom |
Disease and phenotype information
IMPC phenotypes (gene matching)
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).